Grand Pharmaceutical Group Limited (HKG:0512)
4.930
+0.080 (1.65%)
Sep 30, 2026, 4:08 PM HKT
HKG:0512 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, HKG:0512 stock has a consensus rating of "Strong Buy" and an average price target of $9.53. The average 1-year stock price forecast is 93.31% higher than the current stock price, while the lowest is $6.50 (+31.85%) and the highest is $12.00 (+143.41%).
Price Target: $9.53 (+93.31%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:0512 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 5 | 5 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $6.50 | Buy | Maintains | $6.50 | +31.85% | Sep 2, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $10.08 | Buy | Maintains | $10.08 | +104.46% | Sep 1, 2026 |
Financial Forecast
Revenue This Year
12.94B
from 12.28B
Increased by 5.38%
Revenue Next Year
14.10B
from 12.94B
Increased by 8.95%
EPS This Year
0.51
from 0.35
Increased by 43.91%
EPS Next Year
0.56
from 0.51
Increased by 10.29%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is HKD.